The largest database of trusted experimental protocols

34 protocols using a740003

1

Selective P2X7 Receptor Antagonism in Myoblast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A740003 is a potent, selective and competitive P2X7 receptor antagonist that displays selectivity to P2X7 receptor up to a concentration of 100 μM. A740003 (Tocris, # 3701) at 50–100 nM or vehicle (dimethylsulfoxide) was applied to myoblasts 24 h prior to induction of differentiation. GM was replaced with DM containing A740003 or vehicle and cells were fixed at different time points for immunostaining.
+ Open protocol
+ Expand
2

Cytokine Production by Mast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CBMCs were incubated for 3 days at 1 × 106 cells/mL in medium at 37°C with 10 ng/mL recombinant human IL-4 (Invitrogen); BMMCs were untreated prior to assay. Cells were resuspended in fresh medium; rhIL-4 was included for human experiments. In experiments using P2X7 antagonist A740003 (Tocris), cells were incubated with 3 μM A740003 or vehicle (DMSO) in medium for 30 minutes prior to ATP addition. ATP dissolved in sterile ultrapure water and adjusted to pH 7.1 with NaOH or vehicle was applied and cells incubated for 4 hours (PGD2) or 20–24 hours (cytokines). Cells were pelleted and supernatants assayed by ELISA for PGD2 (Cayman Chemical) or IL-13 (eBioscience).
+ Open protocol
+ Expand
3

Monitoring Calcium Signaling in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluo-4-AM (Invitrogen) Ca2+ indicator was prepared in DMSO containing 20% Pluronic F-127. Cells (7×104 cells/well) in poly-L-lysine-coated glass bottom dishes (50 mm; MatTek) were loaded for 20 min with 3 µM Fluo-4-AM in OptiMEM (Invitrogen). Medium was replaced with fresh OptiMEM, and cells were monitored by confocal microscopy during ATP or BzATP (Sigma) stimulation at 37°C and 5% CO2. Real-time videos were acquired (2.62 s between frames, 63× objective) using sequential scanning. For experiments with P2X7R antagonist, cells were loaded with Fluo-4-AM in OptiMEM containing 5 µM A740003 (Tocris) prior to stimulation with agonist in A740003-containing OptiMEM. Images were analyzed using the LAS-AF software (Leica).
+ Open protocol
+ Expand
4

Synthesis and Application of C100814

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthesis and chemical details of C100814 are described in Additional file 1. Drugs were obtained from Sigma-Aldrich or, for MCC950 and A740003, from Tocris. Application of drugs in electrophysiogical experiments was via bath perfusion or locally via pressure ejection from a puffing pipette located at the slice surface (in the case of repeated brief ATP applications).
+ Open protocol
+ Expand
5

Investigating Macrophage Inflammatory Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Key reagents and their sources were as follows: Escherichia coli LPS serotype 055:B5, TNF-α protease inhibitor-0 (TAPI-0) and ATP were from Sigma-Aldrich; selective p38 inhibitor (SB202190) was from Calbiochem Merck-Millipore; P2X7 receptor selective antagonists AZ10606120, A438079, and A740003 were from Tocris. The composition of the physiological buffer used in all experiments to stimulate macrophages with ATP was (in millimoles): 147 NaCl, 10 HEPES, 13 d-glucose, 2 KCl, 2 CaCl2, and 1 MgCl2; pH 7.4.
HEK293T cells (ATCC CRL-11268) were cultured in DMEM:F-12 media (1:1; Lonza) supplemented with 10% of fetal calf serum (Life Technologies) and 2 mM Glutamax (Life Technologies) and were routinely tested for mycoplasma contamination with a Mycoplasma Detection Kit (Roche). Lipofectamine 2000 (Life Technologies) was used according to the manufacturer’s instructions to transfect a plasmid coding for human TNF-α into HEK293T cells.
+ Open protocol
+ Expand
6

Macrophage Differentiation and GAS Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 cells were cultured in RPMI 1640 supplemented with 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 5 mM HEPES, 4.5 mg/ml D-glucose and 0.05 mM 2-mercaptoethanol at 37°C in 5% CO2. Differentiation into macrophages was acquired by stimulation with 5 ng/ml phorbol 12-myristate 13-acetate (PMA) for 48 h. GAS infection of THP-1 cells was performed as described above following 24 h priming with 5 ng/ml LPS. For inhibition of the P2X7 receptor, A-740003 (Tocris) was added 30 min before infection and was present throughout the experiment.
+ Open protocol
+ Expand
7

Melanoma Cell Culture and Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
30 × 103 Ma-Mel-19 or Sk-Mel-28 cells were cultured in RPMI-1640 medium and counted as described in ref. [14 (link)]. Whenever required, A740003 and AZ10606120 (Tocris Bioscience, UK) were added, respectively, at 20 or 2 μM.
+ Open protocol
+ Expand
8

Molecular Mechanisms of G Protein-Coupled Receptor Signaling Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies and their sources were as follows: COX-2 (Cell Signaling Technologies (CST) 12282), β-actin (CST 3700), P-ERK (CST 4370), T-ERK (CST 9102), cPLA2 (CST 2832), STIM1 (Feske Lab #3917), α-Tubulin (Abcam ab52866). Pharmacological tools used in the study were: UTP (Sigma U6875), SLIGKV-NH2 (Tocris 4153), FK-506 (Tocris 3631), BTP2 (Sigma 203890), ATP (Sigma A6419), DiclofeNAC (Tocris 4454), Apocynin (Tocris 4663), NAC (Sigma 106425), U0126 (Tocris 1144), ATPγS (Tocris 4080), AACOCF3 (Tocris 1462), AR-C 118925XX (Tocris 4890), NF546 (Tocris 3892), S3QEL 2 (Tocris 5735), ADPβS (Sigma A8016), UDP (Sigma U4125), NF157 (Tocris 2450), Apyrase (Sigma A6410 Grade VI, High ATPase/ADPase activity), TNP-ATP (Tocris 2464), 5-BDBD (Tocris 3579), A740003 (Tocris 3701), Suramin (ACROS Organics-Fisher AC328540500), PPADS (Tocris 0625), CM4620 was a kind gift from CalciMedica.
+ Open protocol
+ Expand
9

Isolation and Culture of Primary Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue culture media, antibiotics, fetal calf serum (FCS), and NP40 cell lysis buffer (10×) were purchased from Life Technologies (San Giuliano Milanese, Italy); lipopolysaccaride (LPS) (Ultra-Pure LPS-EB from E. coli 0111:B4 strain; only activates TLR4), Pam3CSK4, and ethyl-(6R)-6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate (CLI-095 or TAK 242) were from InvivoGen (Cayla-Invivogen Europe, Toulouse, France); A740003 from Tocris Bioscience, Pittsburgh, PA, USA); poly-L-lysine hydrobromide (mol wt 70,000–150,000), papain, DNase I (bovine pancreas), trypsin inhibitor, L-leucyl-L-leucine methyl ester (L-LME), protease inhibitor cocktail, Pefabloc® SC (100 mM), CU-CPT22, and all other biochemicals were purchased from Sigma-Aldrich (Milan, Italy) unless noted otherwise; recombinant human Apo-SAA (consensus SAA molecule corresponding to human Apo-SAA1α, except for the presence of an N-terminal methionine, the substitution of asparagine for aspartic acid at position 60, and arginine for histidine at position 71) from Peprotech (endotoxin level < 0.1 ng/μg protein; London, UK); QIAzol from Qiagen (Milan, Italy. Falcon tissue culture plastic-ware were purchased from BD Biosciences. Sterilin Petri plastic dishes (10 cm Ø) were obtained from Sarstedt (Verona, Italy).
+ Open protocol
+ Expand
10

Astrocyte Response to Hypotonic Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat and mouse optic nerve head astrocytes were subcultured onto plastic 6-well plates and grown until confluent. Cells were incubated in control isotonic solution containing (in mM) 105 NaCl, 5 KCl, 4 NaHEPES, 6 HEPES acid, 1.3 CaCl2, 5 glucose, 5 NaHCO3 and 60 mannitol, pH 7.4 or in solution made 30% hypotonic solution by addition of dH20, for 4 h in the tissue culture incubator. Cells were pretreated with inhibitors Bay 11-7082 (4 μM), Brilliant blue G (BBG, 10 μM), A839977 (50 nM, Tocris Bioscience), A740003 (5 μM, Tocris Bioscience), carbenoxolone (10 μM, #C4790), probenecid (1 mM, #P8761) or 10Panx1 and scrambled peptide (100 μM, #3348 and #3708, respectively, Tocris Bioscience) for 1 h before adding test solutions. RNA was extracted immediately after the 4 h treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!